Trailing Dividend / Share
$0.00
Bicara Therapeutics Inc. Common Stock (BCAX) Dividend History
Income profile from 2022 to 2025 with payout safety and yield-on-cost trend
Dividend Yield
N/A
Payout Ratio
N/A
Unknown
Dividend Streak
0 years
BCAX Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
BCAX Dividend Scorecard
Yield & Income
Dividend YieldN/A
Trailing DPS$0.00
FrequencyN/A
Payments / 12M0
Payout Safety
Earnings PayoutN/A
Earnings SafetyUnknown
FCF PayoutN/A
FCF SafetyUnknown
Piotroski F-Score1/9
Growth
Growth Streak0 years
3Y CAGRN/A
5Y CAGRN/A
Yield on Cost (5Y)N/A
YOC Trendunknown
Total Returns
Buyback Yield0.0%
Total Shareholder Yield0.0%
1Y Total Return146.3%
5Y Total Return-0.8%
Estimated $10K growth (return + dividends):
5Y ago$9,92310Y ago$9,92320Y ago$9,923
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
BCAX Dividend History
No dividend payment history available
This company has not paid dividends during the available data period.
Get BCAX's next ex-dividend date and payout in your inbox
Monthly dividend calendar — upcoming ex-dates for stocks you follow.
Dividend Analysis
Payout Safety
Bicara Therapeutics Inc. Common Stock has limited earnings payout data (Unknown).
Piotroski F-Score: 1/9 — weak financial health.
Growth Track Record
BCAX does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, BCAX returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is -0.8%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $9,923 today.
BCAX Annual Dividend History (2022–2025)
4 years of dividend data
GrowthDecline
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $-2.52 | — | — | — |
| 2024 | $0.00 | — | 0 | $-1.25 | — | — | — |
| 2023 | $0.00 | — | 0 | $-1.00 | — | — | — |
| 2022 | $0.00 | — | 0 | $-0.73 | — | — | — |
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
4+ years return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
BCAX — Frequently Asked Questions
Quick answers to the most common questions about buying BCAX stock.
How much dividend does BCAX pay per share?
Bicara Therapeutics Inc. Common Stock (BCAX) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is BCAX's next ex-dividend date?
BCAX's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. BCAX typically pays dividends quarterly.
Is BCAX's dividend safe?
BCAX's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has BCAX increased its dividend?
BCAX has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does BCAX pay dividends?
Bicara Therapeutics Inc. Common Stock pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 3+ years from 2022 to 2025.
How much would $10,000 invested in BCAX grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in BCAX five years ago would be worth approximately $9,923 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is BCAX's yield on cost for long-term holders?
BCAX's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.